COmparison of White Light and Linked COlor Imaging for Detection of RIght COlon Polyps

NCT ID: NCT04112563

Last Updated: 2024-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

686 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2022-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of the number of adenomas missed by the first exploration of the right colon by LCI (linked color imaging) or by white light during a colonoscopy, according to the order of randomization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients consecutively admitted for routine colonoscopy will be included in this prospective randomized crossover study. After randomization, a first exploration of the right colon will be performed in linked color imaging (LCI) or white light imaging (WLI) depending of the randomization. Every polyp will be resected as soon it will be detected. After this first examination, colon will be explored a second time with a light system different from the one used for the first exploration. If a polyp will be detected during the second exploration, it will be counted as a polyp missed by the first exploration method.

A- Inclusion criteria:

1. Patient consecutively admitted to one of the endoscopy units for routine colonoscopy (screening, positive FIT, personal or family history of polyp or cancer, symptoms)
2. Patient whose age is greater than or equal to 18 years and less than 90 years
3. Score: ASA 1, ASA 2, ASA 3
4. No participation in another clinical study
5. Signed informed consent

Exclusion criteria:

History of recto-colic resection Inadequate preparation (none under Boston score \<2) Patient referred for resection of a polyp in place, known IBD (inflammatory bowel disease) or known polyposis

B- Exclusion criteria:

1. History of recto-colonic resection
2. Inadequate preparation (none under Boston score \<2)
3. Patient referred for resection of a known polyp
4. Inflammatory Bowel Disease
5. family polyposis
6. Score: ASA 4, ASA 5
7. Pregnant woman
8. Patient with coagulation abnormalities preventing polyp resection: TP \<50%, Platelets \<50000 / mm3, effective anticoagulation in progress, clopidogrel in progress
9. Patient unable to personally consent
10. No signed informed consent

Purposes of the study:

Compare, when exploring the number of adenomas missed by the first exploration of the right colon by LCI or by white light, according to the order of randomization.

Evaluation criteria :

Main criterion:

\- Missed right colon adenomas by first exploration in LCI-WLI and WLI-LCI groups

Secondary criteria

* Rate of polyps missed by the first exploration
* Serrated polyp rate missed by the first exploration
* Advanced adenoma rate missed by the first exploration
* Comparison of ADR, SPDR, given by the first exploration technique decided by randomization

Number of patients:

The expected rate of "missed adenomas" of the colon is about 20%, based on published data. Considering as relevant an 8% reduction in this rate of "missed adenomas" of the right colon by the LCI, the expected rate for LCI is therefore 12%.

With a risk of the first species of 5% (bilateral test), a power of 80%, 329 patients per group should be included in the study. Taking into account the rate lost to follow-up of 5%, we expect a total of 700 patients.

Duration of the study:

1-2 years

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adenoma Colon Colon Polyp Colonoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

the patient will be randomized and included in one of two groups: WLI-LCI group: a first exploration of the right colon will be done in white light (WLI) then a second exploration will be done in LCI LCI-WLI group: a first exploration of the right colon will be done in LCI and a second exploration will be done in white light (WLI)
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

WLI-LCI group

a first exploration of the right colon will be done in white light (WLI) then a second exploration will be done in LCI

Group Type ACTIVE_COMPARATOR

exploration in white light (WLI)

Intervention Type PROCEDURE

Exploration of the right colon done in white light (WLI)

Exploration in LCI

Intervention Type PROCEDURE

Exploration of the right colon in linked color imaging (LCI)

LCI-WLI group

a first exploration of the right colon will be done in LCI and a second exploration will be done in white light (WLI)

Group Type ACTIVE_COMPARATOR

exploration in white light (WLI)

Intervention Type PROCEDURE

Exploration of the right colon done in white light (WLI)

Exploration in LCI

Intervention Type PROCEDURE

Exploration of the right colon in linked color imaging (LCI)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exploration in white light (WLI)

Exploration of the right colon done in white light (WLI)

Intervention Type PROCEDURE

Exploration in LCI

Exploration of the right colon in linked color imaging (LCI)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient consecutively admitted for routine colonoscopy

Exclusion Criteria

* History of recto-colic resection
* Inadequate preparation (none under Boston score \<2)
* Patient referred for resection of a known polyp
* known Inflammatory Bowel Disease (IBD) or known polyposis
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société Française d'Endoscopie Digestive

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

KARSENTI

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David KARSENTI, MD

Role: PRINCIPAL_INVESTIGATOR

Société Française d'Endoscopie Digestive

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Paris-Bercy

Charenton-le-Pont, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID-RCB 2019-A01287-50

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.